Home / TRIM45 Knockout Cell Lines

TRIM45 Knockout Cell Lines

Gene: TRIM45

Official Full Name: tripartite motif containing 45provided by HGNC

Gene Summary: Enables ubiquitin protein ligase activity. Involved in negative regulation of inflammatory response; proteasome-mediated ubiquitin-dependent protein catabolic process; and protein K48-linked ubiquitination. Located in cytosol; intercellular bridge; and nucleoplasm. Is active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO26071 TRIM45 Knockout cell line (HeLa) Human TRIM45 1:3~1:6 Negative Online Inquiry
KO26072 TRIM45 Knockout cell line (HCT 116) Human TRIM45 1:2~1:4 Negative Online Inquiry
KO26073 TRIM45 Knockout cell line (HEK293) Human TRIM45 1:3~1:6 Negative Online Inquiry
KO26074 TRIM45 Knockout cell line (A549) Human TRIM45 1:3~1:4 Negative Online Inquiry

Background

TRIM45 Gene Knockout Cell Lines are advanced mammalian cell lines that have been genetically modified to eliminate the expression of the TRIM45 gene, a member of the tripartite motif-containing (TRIM) protein family known to play roles in various cellular processes, including immune response and cellular homeostasis. By employing the CRISPR/Cas9 gene-editing technology, these cell lines facilitate precise gene editing, allowing researchers to analyze the specific functions of TRIM45 without the interference of its normal protein product.

The primary mechanism of action involves the targeted disruption of TRIM45-specific sequences, leading to a loss-of-function phenotype that can be monitored across multiple biological assays. This knockout model is invaluable for studying the gene's contributions to processes such as autophagy modulation, pathogen response, and cellular stress pathways. It serves as a critical tool for elucidating the pathological role of TRIM45 in diseases, including cancer, autoimmune disorders, and infectious diseases, thus expanding our understanding of disease mechanisms at the molecular level.

In the realm of scientific research and clinical applications, TRIM45 Gene Knockout Cell Lines stand out due to their ability to provide insights into gene function that are often impossible to achieve with wild-type cells. These lines enable researchers to perform higher-throughput screening of compounds, validate potential drug targets, and study the phenotype associated with TRIM45 deficiency in a controlled environment.

What differentiates TRIM45 Gene Knockout Cell Lines from alternative models is their high specificity, reproducibility, and the robust data they generate, which are crucial for advancing both basic and applied science. The knockouts eliminate any confounding effects from TRIM45, allowing for clearer interpretations of experimental data.

For researchers and clinicians striving to push the boundaries of understanding cellular mechanisms, TRIM45 Gene Knockout Cell Lines provide an essential platform. By choosing this product, users gain access to a versatile and reliable tool that supports innovative research and aids in the development of effective therapeutics.

Our company, with its commitment to cutting-edge gene editing technologies and the comprehensive support of our research community, offers a suite of biological products that empower scientists to achieve their research objectives efficiently and effectively.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.